vs
InfuSystem Holdings, Inc（INFU）与READING INTERNATIONAL INC（RDI）财务数据对比。点击上方公司名可切换其他公司
READING INTERNATIONAL INC的季度营收约是InfuSystem Holdings, Inc的1.4倍（$50.3M vs $36.2M），InfuSystem Holdings, Inc同比增速更快（7.0% vs -14.2%），InfuSystem Holdings, Inc自由现金流更多（$7.0M vs $4.1M），过去两年InfuSystem Holdings, Inc的营收复合增速更高（6.4% vs 5.6%）
InfuSystem Holdings, Inc.是总部位于美国的医疗服务及设备供应商，主打输液治疗解决方案，提供可编程输液泵、配套一次性医用耗材及专业临床支持服务，服务覆盖北美地区的肿瘤诊所、家庭医疗服务商及急症护理机构。
雷丁公司是总部位于美国费城的铁路企业，1924年起在宾夕法尼亚州东部及周边各州提供客运与货运运输服务，直至1976年被联合铁路公司收购。
INFU vs RDI — 直观对比
营收规模更大
RDI
是对方的1.4倍
$36.2M
营收增速更快
INFU
高出21.2%
-14.2%
自由现金流更多
INFU
多$2.9M
$4.1M
两年增速更快
INFU
近两年复合增速
5.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $36.2M | $50.3M |
| 净利润 | — | $-2.6M |
| 毛利率 | 56.4% | — |
| 营业利润率 | 10.3% | -1.9% |
| 净利率 | — | -5.1% |
| 营收同比 | 7.0% | -14.2% |
| 净利润同比 | — | -14.5% |
| 每股收益（稀释后） | $0.09 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收INFURDI
| Q4 25 | $36.2M | $50.3M | ||
| Q3 25 | $36.5M | $52.2M | ||
| Q2 25 | $36.0M | $60.4M | ||
| Q1 25 | $34.7M | $40.2M | ||
| Q4 24 | $33.8M | $58.6M | ||
| Q3 24 | $35.3M | $60.1M | ||
| Q2 24 | $33.7M | $46.8M | ||
| Q1 24 | $32.0M | $45.1M |
净利润INFURDI
| Q4 25 | — | $-2.6M | ||
| Q3 25 | $2.3M | $-4.2M | ||
| Q2 25 | $2.6M | $-2.7M | ||
| Q1 25 | $-267.0K | $-4.8M | ||
| Q4 24 | — | $-2.2M | ||
| Q3 24 | $1.8M | $-7.0M | ||
| Q2 24 | $717.0K | $-12.8M | ||
| Q1 24 | $-1.1M | $-13.2M |
毛利率INFURDI
| Q4 25 | 56.4% | — | ||
| Q3 25 | 57.1% | — | ||
| Q2 25 | 55.2% | — | ||
| Q1 25 | 55.2% | — | ||
| Q4 24 | 53.8% | — | ||
| Q3 24 | 53.9% | — | ||
| Q2 24 | 49.5% | — | ||
| Q1 24 | 51.5% | — |
营业利润率INFURDI
| Q4 25 | 10.3% | -1.9% | ||
| Q3 25 | 10.4% | -0.6% | ||
| Q2 25 | 10.5% | 4.8% | ||
| Q1 25 | 1.8% | -17.2% | ||
| Q4 24 | 7.7% | 2.6% | ||
| Q3 24 | 9.2% | -0.6% | ||
| Q2 24 | 5.5% | -16.4% | ||
| Q1 24 | -2.6% | -16.7% |
净利率INFURDI
| Q4 25 | — | -5.1% | ||
| Q3 25 | 6.2% | -8.0% | ||
| Q2 25 | 7.2% | -4.4% | ||
| Q1 25 | -0.8% | -11.8% | ||
| Q4 24 | — | -3.8% | ||
| Q3 24 | 5.1% | -11.7% | ||
| Q2 24 | 2.1% | -27.4% | ||
| Q1 24 | -3.5% | -29.4% |
每股收益（稀释后）INFURDI
| Q4 25 | $0.09 | $-0.11 | ||
| Q3 25 | $0.11 | $-0.18 | ||
| Q2 25 | $0.12 | $-0.12 | ||
| Q1 25 | $-0.01 | $-0.21 | ||
| Q4 24 | $0.05 | $-0.11 | ||
| Q3 24 | $0.08 | $-0.31 | ||
| Q2 24 | $0.03 | $-0.57 | ||
| Q1 24 | $-0.05 | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.2M | $10.5M |
| 总债务越低越好 | $19.6M | $185.1M |
| 股东权益账面价值 | $57.3M | $-18.2M |
| 总资产 | $100.6M | $434.9M |
| 负债/权益比越低杠杆越低 | 0.34× | — |
8季度趋势，按日历期对齐
现金及短期投资INFURDI
| Q4 25 | $3.2M | $10.5M | ||
| Q3 25 | $955.0K | $8.1M | ||
| Q2 25 | $720.0K | $9.1M | ||
| Q1 25 | $1.5M | $5.9M | ||
| Q4 24 | $527.0K | $12.4M | ||
| Q3 24 | $380.0K | $10.1M | ||
| Q2 24 | $146.0K | $9.3M | ||
| Q1 24 | $822.0K | $7.5M |
总债务INFURDI
| Q4 25 | $19.6M | $185.1M | ||
| Q3 25 | $20.9M | — | ||
| Q2 25 | $26.3M | — | ||
| Q1 25 | $28.7M | — | ||
| Q4 24 | $23.9M | $202.7M | ||
| Q3 24 | $28.0M | — | ||
| Q2 24 | $34.2M | — | ||
| Q1 24 | $29.9M | — |
股东权益INFURDI
| Q4 25 | $57.3M | $-18.2M | ||
| Q3 25 | $55.5M | $-12.1M | ||
| Q2 25 | $54.5M | $-7.7M | ||
| Q1 25 | $55.1M | $-8.1M | ||
| Q4 24 | $57.5M | $-4.4M | ||
| Q3 24 | $55.5M | $1.6M | ||
| Q2 24 | $53.5M | $6.5M | ||
| Q1 24 | $52.3M | $18.0M |
总资产INFURDI
| Q4 25 | $100.6M | $434.9M | ||
| Q3 25 | $98.9M | $435.2M | ||
| Q2 25 | $100.8M | $438.1M | ||
| Q1 25 | $104.3M | $441.0M | ||
| Q4 24 | $103.6M | $471.0M | ||
| Q3 24 | $105.3M | $495.7M | ||
| Q2 24 | $108.5M | $494.9M | ||
| Q1 24 | $104.8M | $494.9M |
负债/权益比INFURDI
| Q4 25 | 0.34× | — | ||
| Q3 25 | 0.38× | — | ||
| Q2 25 | 0.48× | — | ||
| Q1 25 | 0.52× | — | ||
| Q4 24 | 0.41× | — | ||
| Q3 24 | 0.50× | — | ||
| Q2 24 | 0.64× | — | ||
| Q1 24 | 0.57× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $7.1M | $4.3M |
| 自由现金流经营现金流 - 资本支出 | $7.0M | $4.1M |
| 自由现金流率自由现金流/营收 | 19.3% | 8.2% |
| 资本支出强度资本支出/营收 | 0.4% | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $23.8M | $-2.9M |
8季度趋势，按日历期对齐
经营现金流INFURDI
| Q4 25 | $7.1M | $4.3M | ||
| Q3 25 | $8.5M | $295.0K | ||
| Q2 25 | $7.0M | $1.6M | ||
| Q1 25 | $1.8M | $-7.7M | ||
| Q4 24 | $7.9M | $8.0M | ||
| Q3 24 | $9.8M | $1.3M | ||
| Q2 24 | $2.3M | $-10.4M | ||
| Q1 24 | $377.0K | $-2.8M |
自由现金流INFURDI
| Q4 25 | $7.0M | $4.1M | ||
| Q3 25 | $8.4M | $-246.0K | ||
| Q2 25 | $6.8M | $1.2M | ||
| Q1 25 | $1.6M | $-8.0M | ||
| Q4 24 | $7.4M | $7.0M | ||
| Q3 24 | $9.8M | $-1.1M | ||
| Q2 24 | $2.0M | $-10.6M | ||
| Q1 24 | $195.0K | $-4.7M |
自由现金流率INFURDI
| Q4 25 | 19.3% | 8.2% | ||
| Q3 25 | 23.1% | -0.5% | ||
| Q2 25 | 18.9% | 1.9% | ||
| Q1 25 | 4.7% | -19.8% | ||
| Q4 24 | 21.9% | 12.0% | ||
| Q3 24 | 27.7% | -1.8% | ||
| Q2 24 | 5.9% | -22.7% | ||
| Q1 24 | 0.6% | -10.4% |
资本支出强度INFURDI
| Q4 25 | 0.4% | 0.3% | ||
| Q3 25 | 0.2% | 1.0% | ||
| Q2 25 | 0.6% | 0.6% | ||
| Q1 25 | 0.4% | 0.6% | ||
| Q4 24 | 1.6% | 1.7% | ||
| Q3 24 | 0.1% | 4.0% | ||
| Q2 24 | 1.0% | 0.5% | ||
| Q1 24 | 0.6% | 4.3% |
现金转化率INFURDI
| Q4 25 | — | — | ||
| Q3 25 | 3.76× | — | ||
| Q2 25 | 2.70× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 5.45× | — | ||
| Q2 24 | 3.22× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
INFU
| Patient Services | $20.0M | 55% |
| Device Solutions | $14.4M | 40% |
| Other | $1.9M | 5% |
RDI
| Cinema Exhibition Segment | $46.9M | 93% |
| Real Estate Revenue | $3.4M | 7% |
